Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma.

ABSTRACT: Isocitrate dehydrogenases (IDH1/2) are central molecular markers for glioblastoma. Providing in vitro or in vivo models with mutated IDH1/2 can help prepare facilities to understand the biology of these mutated genes as glioma markers, as well as help, improve therapeutic strategies. In this review, we first summarize the biology principles of IDH and its mutations and outline the core primary findings in the clinical context of neuro-oncology. Given the extensive research interest and exciting developments in current stem cell biology and genome editing, the central part of the manuscript is dedicated to introducing various routes of disease modeling strategies of IDH mutation (IDH^Mut) glioma and comparing the scientific-technological findings from the field using different eng

SUBMITTER: Mehrjardi NZ 

PROVIDER: S-EPMC7680457 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature